Color Genomics Advances Precision Medicine with New Test for Hereditary Cancers | oneFAPvoice

welcome to oneFAPvoice

- a positively charged Familial Adenomatous Polyposis community.
  • join today!
view full news & meetings section

Color Genomics Advances Precision Medicine with New Test for Hereditary Cancers


Marking its one year anniversary since launching the first-ever widely accessible breast and ovarian cancer risk test, Color Genomics announced a new cancer panel analyzing 30 genes that highly impact the most common hereditary cancers affecting both men and women. Available today, the Color Test analyzes hereditary cancer risks for breast, colorectal, melanoma, ovarian, pancreatic, prostate, stomach, and uterine cancers. The Color Test is physician ordered and includes genetic counseling by a board-certified genetic counselor. The genes included on the broader panel can significantly impact a person’s risk of cancer. For example, a mutation in the APC gene can increase a man or woman’s chance to develop colorectal cancer by age 70 to 70-100% if there are no interventions. Access to genetic information helps individuals and doctors take a data-driven approach to create preventive plans and align with the appropriate screening guidelines relative to their risk. For example, the 5-year survival rate for colorectal cancer increases from 13% to 90% when caught at an earlier more treatable stage.

https://www.fapvoice.com/wp-content/uploads/2016/08/4.jpg

expertly curated content related to this topic

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close